In Vitro Activity of Imipenem-Relebactam Alone or in Combination with Amikacin or Colistin against Pseudomonas aeruginosa (vol 63, e00997-19, 2019)

被引：0
|
作者：
Asempa, Tomefa E. [1 ]
Nicolau, David P. [1 ,2 ]
Kuti, Joseph L. [1 ]
机构：
[1] Hartford Hosp, Ctr Antiinfect Res & Dev, Hartford, CT 06115 USA
[2] Hartford Hosp, Div Infect Dis, Hartford, CT 06115 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2020年 / 64卷 / 05期
关键词：
D O I：
10.1128/AAC.00467-20
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model
    Gomez-Junyent, Joan
    Benavent, Eva
    Sierra, Yanik
    El Haj, Cristina
    Soldevila, Laura
    Torrejon, Benjamin
    Rigo-Bonnin, Raul
    Tubau, Fe
    Ariza, Javier
    Murillo, Oscar
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 53 (05) : 612 - 619
  • [42] In Vitro Activity of Ceftolozane-Tazobactam, Imipenem-Relebactam, Ceftazidime-Avibactam, and Comparators against Pseudomonas aeruginosa Isolates Collected in United States Hospitals According to Results from the SMART Surveillance Program, 2018 to 2020
    Karlowsky, James A.
    Lob, Sibylle H.
    DeRyke, C. Andrew
    Hilbert, David W.
    Wong, Michael T.
    Young, Katherine
    Siddiqui, Fakhar
    Motyl, Mary R.
    Sahm, Daniel F.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (05)
  • [43] In vitro evaluation of the activity of two doses of Levofloxacin alone and in combination with other agents against Pseudomonas aeruginosa
    Burgess, DS
    Hall, RG
    Hardin, TC
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2003, 46 (02) : 131 - 137
  • [44] In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in the Asia-Pacific region: SMART 2017-2020
    Karlowsky, James A.
    Lob, Sibylle H.
    Chen, Wei-Ting
    DeRyke, C. Andrew
    Siddiqui, Fakhar
    Young, Katherine
    Motyl, Mary R.
    Sahm, Daniel F.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023, 62 (03)
  • [45] Clinically Relevant Plasma Concentrations of Colistin in Combination with Imipenem Enhance Pharmacodynamic Activity against Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula
    Bergen, Phillip J.
    Forrest, Alan
    Bulitta, Juergen B.
    Tsuji, Brian T.
    Sidjabat, Hanna E.
    Paterson, David L.
    Li, Jian
    Nation, Roger L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (11) : 5134 - 5142
  • [46] In vitro activities of various antibiotics, alone and in combination with colistin methanesulfonate, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients
    Guezel, Cagla Bozkurt
    Gerceker, A. Alev
    CHEMOTHERAPY, 2008, 54 (02) : 147 - 151
  • [47] INVITRO BACTERICIDAL ACTIVITY OF TOBRAMYCIN AND AMIKACIN ALONE AND IN COMBINATION AGAINST ISOLATES OF PSEUDOMONAS-AERUGINOSA FROM PATIENTS WITH CYSTIC-FIBROSIS
    BERTROU, A
    MARTY, N
    HENRY, S
    AGUEDA, L
    CHABANON, G
    PATHOLOGIE BIOLOGIE, 1990, 38 (05): : 366 - 375
  • [48] In Vitro Activity of Pentamidine Alone and in Combination with Antibiotics against Multidrug-Resistant Clinical Pseudomonas aeruginosa Strains
    Herrera-Espejo, Soraya
    Cebrero-Cangueiro, Tania
    Labrador-Herrera, Gema
    Pachon, Jeronimo
    Eugenia Pachon-Ibanez, Maria
    Alvarez-Marin, Rocio
    ANTIBIOTICS-BASEL, 2020, 9 (12): : 1 - 11
  • [49] In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa
    Giacometti, A
    Cirioni, O
    Barchiesi, F
    Fortuna, M
    Scalise, G
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (05) : 641 - 645
  • [50] Activity of levofloxacin and ciprofloxacin in combination with cefepime, ceftazidime, imipenem, piperacillin-tazobactam and amikacin against different Pseudomonas aeruginosa phenotypes and Acinetobacter spp.
    Drago, L
    De Vecchi, E
    Nicola, L
    Colombo, A
    Guerra, A
    Gismondo, MR
    CHEMOTHERAPY, 2004, 50 (04) : 202 - 210
12345